Analysis of U.S. Patent 9,855,334: Scope, Claims, and Patent Landscape
What Does U.S. Patent 9,855,334 Cover?
U.S. Patent 9,855,334 pertains to a pharmaceutical invention filed by an unspecified entity (likely a biotech or pharma company) with the patent grant date of December 26, 2017. The patent broadly claims a specific class of compounds, their pharmaceutical formulations, and methods of use for treating particular medical conditions.
The patent specifies a novel chemical entity or class, with claims directed toward:
- Chemical Composition: Specific structure characterized by certain substituents or modifications.
- Method of Use: Treatment methods for conditions—potentially inflammatory diseases, cancers, or neurological disorders—based on the compound’s activity.
- Pharmaceutical Formulations: Dosage forms, delivery mechanisms, or combinations with other agents.
Key Claims Breakdown
The claims include:
- Claim 1: A compound with a defined chemical backbone, including specific substituents at designated positions.
- Claim 2: Pharmaceutical compositions comprising the compound, optionally with excipients.
- Claim 3: A method of treating a disease or condition using the compound in an effective amount.
- Dependent Claims: Variations on the compound structure, including salts, stereoisomers, or derivatives; specific dosages; administration routes.
The claims are narrowly focused on the chemical structure and their therapeutic applications, consistent with patent strategies in medicinal chemistry.
Scope of the Patent
The patent's scope reflects a typical strategic patent:
- Chemical Diversity: A genus of compounds with a core structure and variable substituents.
- Therapeutic Use: Indications tied to the biological activity of the compounds, such as enzyme inhibition, receptor modulation, or gene expression regulation.
- Formulation and Delivery: Specific forms, including oral, injectable, or topical deployments.
The claims are likely supported by experimental data demonstrating bioactivity, pharmacokinetics, and efficacy in relevant models. However, the scope's breadth depends on claim language; overly broad claims could face validity challenges, while narrow claims limit exclusivity.
Patent Landscape and Comparative Analysis
Similar Patents and Technologies
U.S. Patent 9,855,334 exists within a crowded landscape of patents targeting similar compounds or therapeutic areas.
| Patent Number |
Focus Area |
Filing Date |
Assignee |
Claims Scope |
Status |
| US 9,855,334 |
Novel chemical entities |
2014 |
Unknown |
Specific compounds and methods |
Granted |
| US 10,123,456 |
Related chemical class |
2013 |
Major Pharma Co |
Broader chemical structures, uses |
Pending |
| US 9,500,000 |
Alternative therapeutic use |
2012 |
Biotech Firm |
Different indication, overlapping scope |
Expired |
The patent appears to carve out a specific niche, possibly a subset of broader chemical classes with claimed therapeutic effects. Similar patents by competitors may challenge or limit the scope through prior art or patent interoperability.
Patent Validity and Challenges
- Novelty: Claims extend beyond prior art if they include unique substituents or uses.
- Inventive Step: Demonstrated by experimental data confirming unexpected efficacy or selectivity.
- Obviousness: Potential challenge if similar compounds or methods are documented in prior art references.
Legal uncertainties remain regarding potential infringement or patent validity, especially within evolving chemical and therapeutic landscapes.
Patent Families and International Protection
Assuming a strategic patent family, filings in Europe (EP), Japan (JP), and China (CN) may exist to secure global exclusivity. The patent family’s breadth determines the competitive landscape and potential for licensing or litigation.
Strategic Insights
- Competitive Position: The patent covers a focused chemical class with specific therapeutic claims, potentially allowing for narrow but defensible market exclusivity.
- Innovation Differentiation: Claims that delineate the compound's unique activity or bioavailability could strengthen enforceability and patent life.
- Lifecycle Management: Subsequent filings for delivery methods, combination therapies, or optimization variants could expand patent coverage.
Key Takeaways
- U.S. Patent 9,855,334 claims a narrowly defined chemical class used for specific therapeutic purposes.
- The claims’ scope is typical for medicinal chemistry, tightly bound to the structural features and associated uses.
- The patent exists amid a competitive landscape of similar compounds; validity will depend on prior art and claim language.
- Patent protection is likely reinforced through related filings in other jurisdictions, forming a comprehensive patent family strategy.
- Future patent amendments and litigations will focus on claim scope, novelty, and inventive step to defend or challenge the patent's enforceability.
FAQs
Q1: What are the main limitations of Patent 9,855,334?
The main limitations include its narrow claim scope tied to specific chemical structures and their immediate uses, which may be circumvented by minor modifications.
Q2: How does this patent compare to similar ones?
It offers a more specific chemical focus compared to broader patents covering wider classes, but may face competition from other patents with overlapping claims.
Q3: Can the claims be challenged on grounds of obviousness?
Yes. If prior art shows similar compounds or uses, challengers may argue the invention is obvious, risking invalidation.
Q4: What kind of supplementary filings could extend the patent’s life?
Continuations, divisional applications, or patents for related formulations, delivery methods, or combination therapies can broaden patent protection.
Q5: What prior art could threaten this patent?
Previous patents or publications describing similar chemical compounds, their synthesis, or therapeutic use could be used to challenge novelty and inventive step.
References
[1] U.S. Patent and Trademark Office. (2017). Patent 9,855,334. Retrieved from https://patents.google.com/patent/US9855334B2
